Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer

Clinical trial NCT06144944 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06144944
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Invasive Hormone-receptor-positive Breast Cancer HER2 Low Breast Carcinoma Early-stage Breast Cancer

Start date: 2024-01-17
Primary completion: 2026-07-18
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.